ES2193186T3 - Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc. - Google Patents

Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc.

Info

Publication number
ES2193186T3
ES2193186T3 ES95903655T ES95903655T ES2193186T3 ES 2193186 T3 ES2193186 T3 ES 2193186T3 ES 95903655 T ES95903655 T ES 95903655T ES 95903655 T ES95903655 T ES 95903655T ES 2193186 T3 ES2193186 T3 ES 2193186T3
Authority
ES
Spain
Prior art keywords
aerosol
propulsing
cfc
gases
drug compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95903655T
Other languages
English (en)
Inventor
Akwete L Adjei
Pramod K Gupta
Lu Mou-Ying Fu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Application granted granted Critical
Publication of ES2193186T3 publication Critical patent/ES2193186T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS PARA DISTRIBUCION POR AEROSOL QUE COMPRENDE UN MEDICAMENTO, UN PROPULSOR SIN CLOROFLUOROCARBONO Y UN COLOIDE PROTECTOR, ASI COMO UN METODO PARA PREPARAR TALES COMPOSICIONES EN EL QUE LA AGREGACION DE PARTICULAS SE EVITA SIN EL USO DE SURFACTANTES O COSOLVENTES.
ES95903655T 1993-12-02 1994-12-02 Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc. Expired - Lifetime ES2193186T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16111593A 1993-12-02 1993-12-02

Publications (1)

Publication Number Publication Date
ES2193186T3 true ES2193186T3 (es) 2003-11-01

Family

ID=22579887

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95903655T Expired - Lifetime ES2193186T3 (es) 1993-12-02 1994-12-02 Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc.

Country Status (10)

Country Link
US (1) US5676931A (es)
EP (1) EP0731688B1 (es)
JP (1) JPH09506097A (es)
AT (1) ATE233544T1 (es)
CA (1) CA2176249C (es)
DE (1) DE69432224T2 (es)
DK (1) DK0731688T3 (es)
ES (1) ES2193186T3 (es)
PT (1) PT731688E (es)
WO (1) WO1995015151A1 (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2455115C (en) * 1991-12-12 2008-05-27 Glaxo Group Limited Pharmaceutical aerosol formulation
EE9700138A (et) * 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
US6193954B1 (en) 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US6129905A (en) * 1997-04-21 2000-10-10 Aeropharm Technology, Inc. Aerosol formulations containing a sugar as a dispersant
US5891419A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe flunisolide aerosol formulations for oral inhalation
US5891420A (en) * 1997-04-21 1999-04-06 Aeropharm Technology Limited Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation
US6284225B1 (en) * 1997-09-29 2001-09-04 Helene Curtis, Inc. Propellant compositions comprising a hydrofluorocarbon and a hydrocarbon
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6136294C1 (en) * 1998-09-22 2002-09-24 Aeropharm Technology Inc Amino acid stabilized medical aerosol formulation
US6458338B1 (en) * 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
PL200941B1 (pl) 1998-11-13 2009-02-27 Jagotec Ag Suchy proszkowy preparat inhalacyjny
US20070212422A1 (en) * 1999-11-10 2007-09-13 Manfred Keller Dry powder for inhalation
US6294153B1 (en) 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US6350432B1 (en) 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
US6485706B1 (en) 1999-06-04 2002-11-26 Delrx Pharmaceutical Corp. Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US20030003057A1 (en) * 2000-07-07 2003-01-02 Jeffry Weers Methods for administering leuprolide by inhalation
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
AU2001247123A1 (en) * 2000-07-19 2002-02-05 Aeropharm Technology, Inc. A medicinal aerosol formulation
PT1372608E (pt) * 2001-03-30 2008-01-04 Jagotec Ag Formulações de aerossol médicas
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
CA2470520A1 (en) * 2001-12-21 2003-07-24 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
JP2005514437A (ja) * 2001-12-21 2005-05-19 スリーエム イノベイティブ プロパティズ カンパニー イオン対複合体を含む医薬用エアロゾル製剤
JP2005514440A (ja) * 2001-12-21 2005-05-19 スリーエム イノベイティブ プロパティズ カンパニー アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物
GB0226274D0 (en) * 2002-11-11 2002-12-18 Medpharm Ltd Metered dose inhalation preparations
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7459146B2 (en) 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0328630D0 (en) * 2003-12-10 2004-01-14 Medpharm Ltd Metered dose inhalation preparations
EP1745247B1 (en) 2004-04-23 2015-11-11 Philip Morris Products S.a.s. Aerosol generators and methods for producing aerosols
WO2007008427A2 (en) * 2005-07-08 2007-01-18 Xemplar Pharmaceuticals, Llc Aerosol compositions and methods
GB0518769D0 (en) 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
PL3111927T3 (pl) 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
GB201306984D0 (en) * 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
WO1992000107A1 (en) * 1990-06-28 1992-01-09 Glaxo Inc. Aerosol drug formulations
WO1992000061A1 (en) * 1990-06-29 1992-01-09 Fisons Plc Pressurised aerosol compositions
US5230884A (en) * 1990-09-11 1993-07-27 University Of Wales College Of Cardiff Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations
GB9024366D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5202110A (en) * 1992-01-22 1993-04-13 Virginia Commonwealth University Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants

Also Published As

Publication number Publication date
DE69432224D1 (de) 2003-04-10
US5676931A (en) 1997-10-14
CA2176249C (en) 2010-06-01
WO1995015151A1 (en) 1995-06-08
ATE233544T1 (de) 2003-03-15
DK0731688T3 (da) 2003-06-23
EP0731688A1 (en) 1996-09-18
JPH09506097A (ja) 1997-06-17
EP0731688B1 (en) 2003-03-05
PT731688E (pt) 2003-07-31
CA2176249A1 (en) 1995-06-08
DE69432224T2 (de) 2003-12-04

Similar Documents

Publication Publication Date Title
ES2193186T3 (es) Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc.
WO1996040089A3 (en) Aerosol drug formulations containing vegetable oils
CA2455115A1 (en) Pharmaceutical aerosol formulation
SE0002643L (sv) Inhalationsberedningar innehållande mikropartiklar
BR9909394A (pt) Composição de aerossol, composição farmacêutica, recipiente, dispositivo de inalação, processo para preparar uma composição de aerossol, mistura de um primeiro material particulado, e, processo para administrar um medicamento particulado
MY119074A (en) Pharmaceutical aerosol composition
EA199900991A1 (ru) Медицинские аэрозольные препараты
DE69231994D1 (de) Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
ES8800037A1 (es) Procedimiento para solubilizar drogas en propulsores de aerosol a base de clorofluorcarburos
ATE287699T1 (de) Pharmazeutische aerosolzusammensetzungen
DK0616525T3 (da) Medikamenter
EP1277467A3 (en) Non-chlorofluorocarbon aerosol formulations
PT711127E (pt) Metodos para a preparacao de lipossomas cheios com gas
NO990454D0 (no) Aerosol-materiale
AR002614A1 (es) Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor
AR009231A1 (es) Formulaciones en aerosol de formoterol.
DE60321774D1 (de) Aerosol-formulierungen von formoterol und mometason
NO980858D0 (no) Farmasöytiske preparater og anordninger for administrering derav
MX9604004A (es) Formualciones de farmaco en aerosol que contienen vitamina e.
MX9707073A (es) Preparaciones de aerosol de prilocaina e hidrofluorocarbono.
CA2215680A1 (en) Prilocaine and hydrofluorocarbon aerosol preparations